Delivery Order SPE2DB20D6037-SPE2DB25FTUZ0
Award Date 3/17/25
Potential Completion Date 3/18/25
Potential Value $1K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at $1,057.44, is for the delivery of Acyclovir 200 mg/5 ml suspension, a common antiviral medication, to support the recurring medical supply needs of Department of Defense (DoD) healthcare facilities. The contract is issued under DMS Pharmaceutical Group's existing...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of Acyclovir 1,000 mg/20 mL vials with a ceiling value of $4,002.58. This firm fixed-price delivery order was awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed in Conshohocken, Pennsylvania. The contract carries no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) as a firm fixed-price delivery order under the SPE2DB program. The $4,665.40 contract is for the delivery of Valacyclovir Hydrochloride, a prescription antiviral medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award from the Defense Logistics Agency (DLA) was issued to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,621.87 firm fixed-price delivery order covers the supply of Valacyclovir Hydrochloride, a prescription antiviral medication, to support the medical needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain program, awarded a delivery order to DMS Pharmaceutical Group Inc. for valacyclovir hydrochloride with a ceiling value of $1,310.07. This firm fixed-price delivery order, issued on September 29, 2025, with an ultimate completion date of October 9, 2025, represents a routine pharmaceutical supply fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA. The award carries no...
- This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $21,834.50 firm fixed-price delivery order contract is for the supply of Valacyclovir Hydroc medical products, with a period of performance ending on May 19, 2025. The award is not associated with a set-aside program. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $2,183.45 for Valacyclovir Hydrochloride on July 18, 2025, with an ultimate completion date of July 28, 2025. This firm fixed-price delivery order was issued by the Defense Logistics Agency's Medical Supply Chain organization and does not include a set-aside designation. The award represents a discrete purchase under DMS Pharmaceutical...
- The Defense Logistics Agency, through its Medical Supply Chain organization, awarded a delivery order to DMS Pharmaceutical Group Inc. for Valacyclovir Hydrochloride with a ceiling value of $2,183.45. The award, issued on September 18, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 29, 2025. This order was placed under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA valued at approximately $500 million and valid...
- This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the Medical Supply Chain division of the Department of Defense (DoD). The contract is valued at $3,804.11 and has an ultimate completion date of August 28, 2024. DMS Pharmaceutical Group Inc. is providing a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,746.96 to DMS Pharmaceutical Group Inc. for Valacyclovir Hydrochloride, with an ultimate completion date of January 5, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating competitive capability in unrestricted federal procurement. This delivery order was issued under DMS...